A vaccine strategy that induces protective immunity against heroin

Journal of Medicinal Chemistry

Volumn 54, Issue 14, 2011, Pages 5195-5204

  Stowe, G Neil ^a   Vendruscolo, Leandro F ^a   Edwards, Scott ^a   Schlosburg, Joel E ^a   Misra, Kaushik K ^a   Schulteis, Gery ^b   Mayorov, Alexander V ^a   Zakhari, Joseph S ^a   Koob, George F ^a   Janda, Kim D ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 [(TERT BUTOXYCARBONYL)AMINO]PROPYL] 2,3,4,4A,7,7A HEXAHYDRO 1H 4,12 METHANOBENZOFURO[3,2 E] 2,3,4,4A,7,7A HEXAHYDRO 1H 4,12 METHANOBENZOFURO[3,2 E] ISOQUINOLINE 7,9 DIYL DIACETATE; ANTIBODY CONJUGATE; CARRIER PROTEIN; DIAMORPHINE; HAPTEN; IMMUNOLOGICAL ADJUVANT; MORPHINE; MORPHINE 6 ACETATE; MORPHINE 6 GLUCURONIDE; OXYCODONE; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTINOCICEPTION; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG CONJUGATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HAPTEN CARRIER COMPLEX; IMMUNE SYSTEM; IMMUNOCHEMISTRY; IMMUNOGENICITY; MALE; NONHUMAN; PROTEIN SYNTHESIS; RAT;

ANIMALS; ANTIBODY SPECIFICITY; CATTLE; DRUG CARRIERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HAPTENS; HEMOCYANIN; HEROIN; HEROIN DEPENDENCE; HOT TEMPERATURE; IMMUNOCONJUGATES; MALE; MOLECULAR STRUCTURE; MORPHINE; NARCOTICS; PAIN; PSYCHOTROPIC DRUGS; RATS; RATS, WISTAR; RECURRENCE; SELF ADMINISTRATION; SERUM ALBUMIN, BOVINE; STRUCTURE-ACTIVITY RELATIONSHIP; TOUCH; VACCINES;

EID: 79960649757     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm200461m     Document Type: Article

References (37)

1. Aceijas, C.; Stimson, G.; Hickman, M.; Rhodes, T. Global overview of injection drug use and HIV infection among injection drug users AIDS 2004, 18, 2296-2303
2. Treatment admissions for injection drug abuse. In The DASIS Report; Substance Abuse and Mental Health Services Administration, Office of Applied Studies: Rockville, MD, June 21, 2002.
3. Mark, T. L.; Woody, G. E.; Juday, T.; Kleber, H. D. The economic costs of heroin addiction in the United States Drug Alcohol Depend. 2001, 61, 195-206 (Pubitemid 32008534)
4. June 25-27 Declaration of Commitment on HIV/AIDS. United Nations General Assembly Special Session on HIV/AIDS: Geneva, 2001.
5. Gillies, P.; Tolley, K.; Wostenholme, J. Is AIDS a disease of poverty? AIDS Care 1996, 8, 351-363 (Pubitemid 26164421)
6. Tawil, O.; Verster, A.; O'Reilly, K. Enabling approaches for HIV/AIDS prevention: can we modify the environment and minimize the risk? AIDS 1995, 9, 1299-1306
7. Moreno, A. Y.; Azar, M. R.; Warren, N. A.; Dickerson, T. J.; Koob, G. F.; Janda, K. D. A Critical Evaluation of a Nicotine Vaccine within a Self-Administration Behavioral Model Mol. Pharmaceutics 2010, 7 (2) 431-441
8. Moreno, A.; Janda, K. Immunopharmacotherapy: vaccination strategies as a treatment for drug abuse and dependence Pharmacol., Biochem. Behav. 2009, 92, 199-205
9. Kosten, T.; Owens, M. Immunotherapy for the treatment of drug abuse Pharmacol. Ther. 2005, 76-85 (Pubitemid 41377120)
10. Maurer, P.; Jennings, G. T.; Willers, J.; Rohner, F.; Lindman, Y.; Roubicek, K.; Renner, W. A.; Muller, P.; Bachmann, M. F. A therapeutic vaccine for nicotine dependence: preclinical efficacy and phase I safety and immunogenicity Eur. J. Immunol. 2005, 35 (7) 2031-2040 (Pubitemid 41015042)
11. Carrera, M.; Ashley, J.; Wirsching, P.; Koob, G.; Janda, K. A second-generation vacine suppresses psychoactive effects of cocaine in the rat Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 1988-1992 (Pubitemid 32165610)
12. Carrera, M.; Ashley, J.; Parsons, L.; Wirsching, P.; Koob, G.; Janda, K. Suppression of psychoactive effects of cocaine by active immunization Nature 1995, 378, 727-730 (Pubitemid 26001945)
13. Bonese, K. F.; Wainer, B. H.; Fitch, F. W.; Rothberg, R. M.; Schuster, C. R. Changes in heroin self-administration by a rhesus monkey after morphine immunization Nature 1974, 252 (5485) 708-710
14. Anton, B.; Leff, P. A novel bivalent morphine/heroin vaccine that prevents relapse to heroin addiction in rodents Vaccine 2006, 24 (16) 3232-3240
15. Rook, E.; Hillebrand, M.; Rosing, H.; van Ree, J.; Beijnen, J. Population pharmacokinetics of heroin and its major metabolites Clin. Pharmacokinet. 2006, 45 (4) 401-417
16. Osborne, R.; Thompson, P.; Joel, S.; Trew, D.; Patel, N.; Slevin, M. The analgesic activity of morphine-6-glucuronide Br. J. Clin. Pharmacol. 1992, 34, 130-138
17. Kuo, C. K.; Hanioka, N.; Hoshikawa, Y.; Oguri, K.; Yoshimura, H. Species difference of site-selective glucuronidation of morphine J. Pharmacobio-dyn. 1991, 14, 187-193
18. Oldendorf, W.; Hyman, S.; Braun, L.; Oldendorf, S. Blood-brain barrier: penetration of morphine, codeine, heroin and methadone after carotid injection Science 1972, 178, 984-987
19. Skibinski, D.; O'Hagan, D., Adjuvants. In Vaccine Design: Innovative Approaches and Novel Strategies; Rappuoli, R.,; Bagnoli, F. ed.; Caister Academic Press: Norfolk, UK, 2011; pp 139-169.
20. Glenny, A. T.; Pope, C. G.; Waddington, H.; Wallace, U. The antigenic value of toxiod preciptated by potassium alum J. Pathol. Bacteriol. 1926, 29, 31-40
21. Marrack, P.; McKee, A. S.; Munks, M. W. Towards an understanding of the adjuvant action of aluminum Nature Rev. 2009, 9, 287-293
22. Morris, B.; Robinson, J.; Piall, E.; Aherne, G.; Marks, V. Development of a radioimmunoassay for morphine having minimal cross-reactivity with codeine J. Endocrinol. 1975, 64 (1) 6P-7P
23. Matsushita, M.; Hoffman, T.; Ashley, J.; Wirsching, P.; Lerner, R.; Janda, K. Cocaine catalytic antibodies: the importance of linker effects Bioorg. Med. Chem. 2001, 11, 87-90 (Pubitemid 32099616)
24. Olofson, R. New, useful reactions of novel haloformates and related reagents Pure Appl. Chem. 1988, 60 (11) 1715-1724
25. Boeglin, D.; Lubell, W. D. Aza-Amino Acid Scanning of Secondary Structure Suited for Solid-Phase Peptide Synthesis with Fmoc Chemistry and Aza-Amino Acids with Heteroatomic Side Chains J. Comb. Chem. 2005, 7 (6) 864-878 (Pubitemid 41705917)
26. Bray, B.; Kelly, D.; Mack, P.; Martin, R.; Wakelin, L. DNA-binding compounds. III. Synthesis of a peptide-linked binuclear platinum(II)-terpyridine complex Aust. J. Chem. 1990, 43 (3) 629-634
27. Muller, R. Determination of affinity and specificity of anti-hapten antibodies by competitive radioimmunoassay Methods Enzymol. 1983, 92, 589-601 (Pubitemid 14004096)
28. Walker, J.; Chen, S.; Moffitt, H.; Inturrisi, C.; Koob, G. Chronic opioid exposure produces increased heroin self-administration in rats Pharmacol., Biochem. Behav. 2003, 75 (2) 349-354 (Pubitemid 36859821)
29. Moreno, A.; Mayorov, A.; Janda, K. Impact of Distinct Structures for the Development of a Methamphetamine Vaccine J. Am. Chem. Soc. 2011, 133, 6587-6595
30. Tomei, E.; Renaud, F. L. Effect of morphine on Fc-mediated phagocytosis by murin macrophages in vitro J. Neuroimmunol. 1997, 74, 111-116 (Pubitemid 27128984)
31. Roy, S.; Cain, K. J.; Chapin, R. B.; Charboneau, R. G.; Barke, R. A. Morphine modulates NFkB activation in macrophages Biochem. Biophys. Res. Commun. 1998, 245, 392-396 (Pubitemid 28418511)
32. Neville, G.; Ekiel, I.; Smith, I. High-resolution proton magnetic resonance spectra of morphine and its three O -acetyl derivatives Magn. Reson. Chem. 1987, 25, 31-35
33. Zinieris, N.; Leondiadis, L.; Ferderigos, N. Nα-Fmoc Removal from Resin-Bound Amino Acids by 5% Piperidine Solution J. Comb. Chem. 2004, 7 (1) 4-6
34. Fransson, R.; Botros, M.; Sköld, C.; Nyberg, F.; Lindeberg, G.; Hallberg, M.; Sandström, A. Discovery of Dipeptides with High Affinity to the Specific Binding Site for Substance P1-7 J. Med. Chem. 2010, 53 (6) 2383-2389
35. King, T.; Vera-Portocarrero, L.; Gutierrez, T.; Vanderah, T.; Dussor, G.; Lai, J.; Fields, H.; Porreca, F. Unmasking the tonic-aversive state in neuropathic pain Nature Neurosci. 2009, 12, 1364-1366
36. Dixon, W. Efficient analysis of experimental obervations Annu. Rev. Pharmacol. Toxicol. 1980, 20, 441-462
37. Vendruscolo, L. F.; Schlosburg, J. E.; Misra, K. K.; Chen, S.; Greenwell, T. N.; Koob, G. F. Escalation patterns of varying periods of heroin access Pharmacol., Biochem. Behav. 2011, 98, 570-574